China · Delayed Price · Currency is CNY Intco Medical Technology Statistics
Total Valuation
SHE:300677 has a market cap or net worth of CNY 26.76 billion. The enterprise value is 31.86 billion.
| Market Cap | 26.76B |
| Enterprise Value | 31.86B |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Jun 11, 2026 |
Share Statistics
SHE:300677 has 647.73 million shares outstanding. The number of shares has decreased by -5.37% in one year.
| Current Share Class | 647.73M |
| Shares Outstanding | 647.73M |
| Shares Change (YoY) | -5.37% |
| Shares Change (QoQ) | -24.29% |
| Owned by Insiders (%) | 35.95% |
| Owned by Institutions (%) | 14.31% |
| Float | 414.84M |
Valuation Ratios
The trailing PE ratio is 37.66 and the forward PE ratio is 10.95.
| PE Ratio | 37.66 |
| Forward PE | 10.95 |
| PS Ratio | 2.59 |
| PB Ratio | 1.44 |
| P/TBV Ratio | 1.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 15.13 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 47.70 |
| EV / Sales | 3.09 |
| EV / EBITDA | 15.64 |
| EV / EBIT | 30.45 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.84, with a Debt / Equity ratio of 0.95.
| Current Ratio | 0.84 |
| Quick Ratio | 0.73 |
| Debt / Equity | 0.95 |
| Debt / EBITDA | 8.66 |
| Debt / FCF | -28.59 |
| Interest Coverage | 2.83 |
Financial Efficiency
Return on equity (ROE) is 3.80% and return on invested capital (ROIC) is 3.59%.
| Return on Equity (ROE) | 3.80% |
| Return on Assets (ROA) | 1.69% |
| Return on Invested Capital (ROIC) | 3.59% |
| Return on Capital Employed (ROCE) | 5.03% |
| Weighted Average Cost of Capital (WACC) | 3.77% |
| Revenue Per Employee | 797,382 |
| Profits Per Employee | 51,620 |
| Employee Count | 12,941 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 5.26 |
Taxes
In the past 12 months, SHE:300677 has paid 182.86 million in taxes.
| Income Tax | 182.86M |
| Effective Tax Rate | 20.80% |
Stock Price Statistics
The stock price has increased by +70.25% in the last 52 weeks. The beta is 0.16, so SHE:300677's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | +70.25% |
| 50-Day Moving Average | 50.67 |
| 200-Day Moving Average | 44.46 |
| Relative Strength Index (RSI) | 28.73 |
| Average Volume (20 Days) | 13,892,205 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300677 had revenue of CNY 10.32 billion and earned 668.01 million in profits. Earnings per share was 1.10.
| Revenue | 10.32B |
| Gross Profit | 2.54B |
| Operating Income | 1.05B |
| Pretax Income | 879.26M |
| Net Income | 668.01M |
| EBITDA | 2.04B |
| EBIT | 1.05B |
| Earnings Per Share (EPS) | 1.10 |
Balance Sheet
The company has 12.86 billion in cash and 17.64 billion in debt, with a net cash position of -4.78 billion or -7.38 per share.
| Cash & Cash Equivalents | 12.86B |
| Total Debt | 17.64B |
| Net Cash | -4.78B |
| Net Cash Per Share | -7.38 |
| Equity (Book Value) | 18.57B |
| Book Value Per Share | 36.39 |
| Working Capital | -3.05B |
Cash Flow
In the last 12 months, operating cash flow was 1.77 billion and capital expenditures -2.39 billion, giving a free cash flow of -617.19 million.
| Operating Cash Flow | 1.77B |
| Capital Expenditures | -2.39B |
| Depreciation & Amortization | 989.94M |
| Net Borrowing | 2.68B |
| Free Cash Flow | -617.19M |
| FCF Per Share | -0.95 |
Margins
Gross margin is 24.60%, with operating and profit margins of 10.14% and 6.47%.
| Gross Margin | 24.60% |
| Operating Margin | 10.14% |
| Pretax Margin | 8.52% |
| Profit Margin | 6.47% |
| EBITDA Margin | 19.73% |
| EBIT Margin | 10.14% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 0.36%.
| Dividend Per Share | 0.15 |
| Dividend Yield | 0.36% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 73.96% |
| Buyback Yield | 5.37% |
| Shareholder Yield | 5.73% |
| Earnings Yield | 2.50% |
| FCF Yield | -2.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SHE:300677 is 63.37, which is 57.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 63.37 |
| Price Target Difference | 57.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 21.33% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on June 13, 2022. It was a forward split with a ratio of 1.2.
| Last Split Date | Jun 13, 2022 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
SHE:300677 has an Altman Z-Score of 1.47 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.47 |
| Piotroski F-Score | 5 |